$3.52
10.20% yesterday
NYSE, Nov 15, 10:00 pm CET
ISIN
US9013841070
Symbol
TSVT
Sector
Industry

2seventy bio Stock price

$3.52
-1.44 29.03% 1M
-1.35 27.72% 6M
-0.75 17.56% YTD
+1.19 51.07% 1Y
-33.73 90.55% 3Y
-10.25 74.44% 5Y
-10.25 74.44% 10Y
NYSE, Closing price Fri, Nov 15 2024
-0.40 10.20%
ISIN
US9013841070
Symbol
TSVT
Sector
Industry

Key metrics

Market capitalization $181.27m
Enterprise Value $236.32m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.18
P/S ratio (TTM) P/S ratio 3.97
P/B ratio (TTM) P/B ratio 0.79
Revenue growth (TTM) Revenue growth -68.73%
Revenue (TTM) Revenue $45.62m
EBIT (operating result TTM) EBIT $-142.33m
Free Cash Flow (TTM) Free Cash Flow $-140.90m
Cash position $192.40m
EPS (TTM) EPS $-1.86
P/E forward negative
P/S forward 3.55
EV/Sales forward 4.52
Short interest 12.73%
Show more

Is 2seventy bio a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

2seventy bio Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a 2seventy bio forecast:

2x Buy
40%
2x Hold
40%
1x Sell
20%

Analyst Opinions

5 Analysts have issued a 2seventy bio forecast:

Buy
40%
Hold
40%
Sell
20%

Financial data from 2seventy bio

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
46 46
69% 69%
100%
- Direct Costs 25 25
34% 34%
56%
20 20
81% 81%
44%
- Selling and Administrative Expenses 43 43
31% 31%
95%
- Research and Development Expense 111 111
49% 49%
243%
-134 -134
23% 23%
-293%
- Depreciation and Amortization 8.47 8.47
12% 12%
19%
EBIT (Operating Income) EBIT -142 -142
23% 23%
-312%
Net Profit -95 -95
49% 49%
-207%

In millions USD.

Don't miss a Thing! We will send you all news about 2seventy bio directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

2seventy bio Stock News

Neutral
Seeking Alpha
3 days ago
2seventy bio, Inc. (NASDAQ:TSVT ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Morgan Shields – Corporate Communications Chip Baird – Chief Executive Officer Vicki Eatwell – Chief Financial Officer Conference Call Participants Samantha Semenkow – Citi Daina Graybosch – Leerink Partners Operator Good day and thank you for standing by. Welcome to the 2seventy...
Neutral
Business Wire
4 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), today reported financial results and recent highlights for the third quarter ended September 30, 2024. “We are very pleased to report 42% sequential growth in quarterly Abecma sales, which was part of a continued expansion of the CAR-T class into earlier lines for multiple myeloma. When combined with the significant progress ...
Neutral
Business Wire
11 days ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT) will announce its third quarter 2024 financial results on Tuesday, November 12, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the financial results conference call live via webcast which will be available on the Investors and Media page of the company's website at https://ir.2seventy...
More 2seventy bio News

Company Profile

2seventy Bio, Inc. operates as cell and gene therapy company. It is focused on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

Head office United States
CEO Chip Baird
Employees 274
Founded 2021
Website www.2seventybio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today